We describe here that mice treated with AAV9‐TRF1 gene therapy showed significant improvements in health span, such as delayed anemia, and improvements in neuromuscular coordination, memory, epithelial barrier fitness, and glucose metabolism. The gene discussed is TERF1; the disease is anemia (phenotype).